ARCHIVES

Industry Groups Lobby for Lower Standards for FDA Approval

This article is from The Cancer Letter archive.

Vol. 37 No. 43 | November 18, 2011

Download PDF Visit The Full Archive

Related Articles

Celgene Begins Two Studies With Hoffmann-La Roche.

June 29, 2001

Guest Editorial: caBIG Has Another Fundamental Problem: It Relies On “Incoherent” Messaging Standard

April 22, 2011

Hollings Resolution Recognizes 20th Year Of National Cancer Act

May 3, 1991

DCE Board Approves Recompetition Concepts

March 18, 1988

NCI Anticipates 60% Decline In Number Of New Trials By Cooperative Groups.

January 12, 2007

FDA Deputy Commissioner Gottlieb To Return To AEI.

December 15, 2006